Statistics
Publications
1
Citations
62
H-Index
1
Active since
2022
Affiliations
Poseida Therapeutics (United States)(Current)
Karl Marquez is an author at Poseida Therapeutics (United States) specializing in rna editing, cas nuclease engineering, and catalytically dead cas9 effectors.
Publications per year
2022–2022
1
1
1–1 of 1